American Thoracic Society - Sanofi Investor Call

sanofi 01 Agenda American Thoracic Society - Sanofi Investor Call Leadership in immunology Dietmar Berger, MD, PhD 05 Global Head of R&D ad interim 02 Lead with Dupixent® in Type 2 06 Elizabeth Laws, PhD Global Program Head, DupixentⓇ 03 Dupixent® BOREAS data in COPD Surya Bhatt, MD, MSPH Associate Professor of Medicine, University of Alabama at Birmingham 04 Q&A (Part 1) Klaus F. Rabe, MD, PhD, FERS Professor of Medicine, LungenClinic Großhansdorf, Germany Expand and disrupt beyond Type 2 Naimish Patel, MD Therapeutic Area Head, Immunology & Inflammation Unlock sustainable growth in Immunology Bill Sibold, Executive Vice President, Specialty Care 07 Q&A (Part 2) 4 ATS Investor Call

View entire presentation